Our findings are partially consistent with those reported by Johnson et al. [8], which highlighted that individuals with obesity undergoing treatment with GLP-1 receptor agonists (GLP-1RAs) often fail to meet the Dietary Reference Intakes (DRIs) for several essential nutrients. This evidence concerns the gene GLP1R and Obesity.